Carter Todd Alfred — SEC insider filings

SEC reporting owner CIK 1944011. 20 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2022-09-21 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Voyager Therapeutics, Inc. (VYGR)Chief Scientific Officer20—18 legs · 52,364 sh · $367,88616

Insider filings — Carter Todd Alfred

FiledFormIssuerReported transactionsSource
2026-11-034Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 33,000 @ $0 · Grant/award (A): 154,000 (derivative) @ $0EDGAR
2026-02-264Voyager Therapeutics, Inc. (VYGR)Sale (S): 4,174 @ $3.76EDGAR
2026-02-204Voyager Therapeutics, Inc. (VYGR)Sale (S): 3,301 @ $3.44EDGAR
2026-02-114Voyager Therapeutics, Inc. (VYGR)Sale (S): 3,525 @ $3.85EDGAR
2026-02-104Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 33,000 @ $0 · Grant/award (A): 154,000 (derivative) @ $0EDGAR
2025-02-244Voyager Therapeutics, Inc. (VYGR)Sale (S): 3,305 @ $4.26 · Grant/award (A): 46,000 @ $0 · Grant/award (A): 92,000 (derivative) @ $0EDGAR
2025-02-124Voyager Therapeutics, Inc. (VYGR)Sale (S): 5,413 @ $4.45EDGAR
2025-01-154Voyager Therapeutics, Inc. (VYGR)Sale (S): 1,191 @ $5.13EDGAR
2024-02-224Voyager Therapeutics, Inc. (VYGR)Sale (S): 602 @ $7.68 · Sale (S): 3,365 @ $7.47EDGAR
2024-02-164Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 38,500 @ $0 · Grant/award (A): 77,000 (derivative) @ $0EDGAR
2024-01-194Voyager Therapeutics, Inc. (VYGR)Sale (S): 1,266 @ $7.18EDGAR
2023-09-184Voyager Therapeutics, Inc. (VYGR)Option exercise (M): 5,000 @ $2.85 · Sale (S): 10,500 @ $8.16 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-07-104Voyager Therapeutics, Inc. (VYGR)Sale (S): 5,500 @ $10.80EDGAR
2023-07-054Voyager Therapeutics, Inc. (VYGR)Option exercise (M): 5,000 @ $2.85 · Sale (S): 5,000 @ $11.41 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-03-224Voyager Therapeutics, Inc. (VYGR)Sale (S): 2,193 @ $7.76EDGAR
2023-02-224Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 34,000 @ $0 · Sale (S): 738 @ $7.45 · Grant/award (A): 68,000 (derivative) @ $0EDGAR
2023-02-154Voyager Therapeutics, Inc. (VYGR)Sale (S): 797 @ $7.67EDGAR
2023-01-194Voyager Therapeutics, Inc. (VYGR)Sale (S): 706 @ $9.57 · Sale (S): 400 @ $10.34EDGAR
2023-01-104Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 388 @ $5.17 · Sale (S): 388 @ $6.41EDGAR
2022-09-214Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 165,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1944011 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs